Results

Total Results: 423 records

Showing results for "aspirin".

201. High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2013%20(4).pdf
     November 01, 2013 - For example, aspirin used to prevent heart disease or cancer can also increase the risk of serious … to Prevent Myocardial Infarction: Men Ages 45 to 79 Years The USPSTF recommends the use of aspirin … A Aspirin to Prevent Ischemic Stroke: Women Ages 55 to 79 Years The USPSTF recommends the use of aspirin … the use of aspirin for myocardial infarction prevention in men younger than age 45 years. … the use of aspirin for stroke prevention in women younger than age 55 years.

202. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening
     November 15, 2008 - change management, including the management of hypertension or the use of lipid-lowering agents and aspirin

203. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
     November 15, 2008 - change management, including the management of hypertension or the use of lipid-lowering agents and aspirin

204. Sixth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/sixth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     December 01, 2017 - Vitamin Supplementation (Nutrients and Multivitamins) to Prevent Cancer and Cardiovascular Disease Aspirin

205. Draft Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/statin-use-primary-prevention-cardiovascular-disease-adults
     July 09, 2020 - Question on risk prediction instruments is currently being addressed in a separate USPSTF review on aspirin

206. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening
     August 08, 2005 - conventional risk factors alone (e.g., through earlier or more aggressive use of treatments, such as aspirin … There was no association between the outcome measures and aspirin, angiotensin-converting enzyme (ACE … conventional risk factors alone (e.g., through earlier or more aggressive use of treatments, such as aspirin

207. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening-2005
     August 08, 2005 - conventional risk factors alone (e.g., through earlier or more aggressive use of treatments, such as aspirin … There was no association between the outcome measures and aspirin, angiotensin-converting enzyme (ACE … conventional risk factors alone (e.g., through earlier or more aggressive use of treatments, such as aspirin

208. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_nVeFxDCT9L-_cnDf_V3fK
     July 17, 2018 - 20%) were combined to conform to the current USPSTF recommendation to initiate pre- ventive low-dose aspirin … by a rare event rate.42,50 In the 1 trial reporting major bleeding, the association with low- dose aspirin … (100 mg daily) and placebo However, AAA found a trend for increased bleeding events in the aspirin group … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive … Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial

209. Final Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
     March 21, 2024 - tamoxifen, raloxifene, or aromatase inhibitors) Comparisons with other types of medications (e.g., aspirin

210. Draft Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
     December 28, 2023 - tamoxifen, raloxifene, or aromatase inhibitors) Comparisons with other types of medications (e.g., aspirin

211. Nominate a Recommendation Statement Topic | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/nominate-recommendation-statement-topic-0
     April 01, 2019 - Preventive medications, such as aspirin for preventing stroke or heart disease.

212. Nominate a Recommendation Statement Topic | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominate-recommendation-statement-topic
     April 01, 2019 - Preventive medications, such as aspirin for preventing stroke or heart disease.

213. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     December 01, 2011 - Treatment for Depression in Children Screening and Counseling for Alcohol Misuse in Adolescents Aspirin

214. U.S. Preventive Services Task Force Focuses on Evidence Gaps Related to Women’s Health in 2015 Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/annlrpt2015bulletin.pdf
     January 01, 2016 - recommendation statements on topics ranging from screening for speech and language delay in children to aspirin

215. Archived: Final Research Plan: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan36/carotid-artery-stenosis-screening-december-2007
     January 23, 2014 - people with asymptomatic CAS (defined as 60% to 99% stenosis), does the addition of medications (e.g., aspirin … Treatment/ management interventions CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet

216. Archived: Final Research Plan: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/ResearchPlanFinal/carotid-artery-stenosis-screening-december-2007
     January 23, 2014 - people with asymptomatic CAS (defined as 60% to 99% stenosis), does the addition of medications (e.g., aspirin … Treatment/ management interventions CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet

217. Archived: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2003
     February 04, 2003 - high‐quality RCTs: tight glycemic control, tight blood pressure control, treatment of dyslipidemia, and aspirin … Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal … Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the u.s. … Aspirin therapy in diabetes. Diabetes Care . 1997;20:1767–71. 51. … Aspirin therapy in diabetes.  Diabetes Care 2000;23:S61–S62. 52.

218. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
     November 01, 2012 - aspirin to Prevent ischemic Stroke: Women ages 55 to 79 years a The USPSTF recommends the use of aspirin … D aspirin to Prevent ischemic Stroke: Women younger than age 55 years The USPSTF recommends against … the use of aspirin for stroke prevention in women younger than age 55 years. … D routine aspirin or NSaiD use for the Primary Prevention of colorectal cancer: Preventive medication … i aspirin to Prevent cardiovascular Disease: adults ages 80 years or Older The USPSTF concludes that

219. U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2021 Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/2021-annual-report-congress-bulletin.pdf
     January 01, 2021 - Topics featured in the report include: • Screening for Hypertension in Adults • Aspirin Use to Prevent

220. U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2016 Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/high-priority.pdf
     December 16, 2016 - Vitamin Supplementation (Nutrients and Multivitamins) to Prevent Cancer and Cardiovascular Disease • Aspirin